BioCentury
ARTICLE | Company News

ML Labs and Vectura drug delivery deal

September 14, 2000 7:00 AM UTC

Innovata Biomed, a subsidiary of ML Laboratories (LSE:MLB), and Vectura ( Cambridge, U.K.) will collaborate to develop systemically active protein and peptide products for delivery through inhalation....